alexa Microbiota And Mental Health With The Emphasize Of The Role Of Autoantibodies
ISSN: 2153-0645

Journal of Pharmacogenomics & Pharmacoproteomics
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

2nd International Conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics
November 03-05, 2014 Embassy Suites Las Vegas, USA

Afaf El-Ansary
ScientificTracks Abstracts: J Pharmacogenomics Pharmacoproteomics
DOI: 10.4172/2153-0645.S1.002
Abstract
The gut microbiota is increasingly recognized as a complex signaling network that impacts on many systems beyond the enteric system modulating, among others, cognitive functions including learning, memory and decision-making processes. This has led to the concept of a microbiota-driven gut-brain axis, reflecting a bidirectional interaction between the brain and the gut. Immune mechanisms that maintain intestinal homeostasis tend to minimize contact of intestinal bacteria with the gut epithelium. A breakdown in homeostasis usually leads to overproduction of various inflammatory mediators which promote epithelial and endothelial injury and dysfunction leading to ulcerations, fibrosis, and edema. Recently new data further validates a role for molecular mimicry and auto- antibodies in mediating the gut-brain axis and subsequently participating in the development of depressive and brain related disorders. Understanding the pathophysiologic mechanisms involving the bidirectional brain- gut axis signaling and the impact of alteration of gut-microbiota on functional and behavioral changes in animals as well as in clinical studies could help to suggest that modulation of the gut-microbiota by therapeutic (e.g. probiotic and pre-biotic) agents opens a new promising strategy for stress-related disorders, particularly in the aspects of functional GI disorders.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords